Article
Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nature reviews. Clinical oncology - 1 Sept 2016
Tung Nadine, Domchek Susan M, Stadler Zsofia, Nathanson Katherine L, Couch Fergus, Garber Judy E, Offit Kenneth, Robson Mark E
Abstract excerpt
The use of multigene panels for the assessment of cancer susceptibility is expanding rapidly in clinical practice, particularly in the USA, despite concerns regarding the uncertain clinical validity for some gene variants and the uncertain clinical utility of most multigene panels. So-called 'moderate-penetrance' gene mutations associated with cancer susceptibility are identified in approximately 2-5% of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
